C57BL/6JCya-Aurkbem1/Cya
Common Name:
Aurkb-KO
Product ID:
S-KO-15932
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Aurkb-KO
Strain ID
KOCMP-20877-Aurkb-B6J-VA
Gene Name
Product ID
S-KO-15932
Gene Alias
AIM-1; AIRK2; Aik2; Aim1; Ark2; AurB; IPL1; STK-1; Stk12; Stk5
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
11
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Aurkbem1/Cya mice (Catalog S-KO-15932) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000021277
NCBI RefSeq
NM_011496.2
Target Region
Exon 2~6
Size of Effective Region
~1095 bp
Detailed Document
Overview of Gene Research
Aurkb, also known as Aurora kinase B, is a component of the chromosomal passenger protein complex. It plays a critical role in mitosis, regulating chromosome segregation, cell cycle checkpoint, and DNA damage response (DDR) [3]. It is also involved in normal physiological processes. In the context of cancer, it has emerged as an important carcinogenic factor [6].
Aurkb is significantly overexpressed in multiple cancers, such as hepatocellular carcinoma (HCC), bladder cancer, gastric cancer, and intrahepatic cholangiocarcinoma (ICC) [1,2,4,5]. In HCC, down-regulation of Aurkb inhibits cell proliferation, migration, invasion, induces apoptosis, and causes cell cycle arrest, and also inhibits lung metastasis. It interacts with DHX9 and promotes HCC progression through the PI3K/AKT/mTOR pathway [1]. In bladder cancer, knockdown of Aurkb suppresses cell proliferation, migration, invasion, and cell cycle progression, and induces senescence, and these effects can be rescued by MAD2L2 overexpression as Aurkb activates MAD2L2 to down-regulate the p53 DDR pathway [2]. In gastric cancer, silencing Aurkb inhibits cell proliferation, arrests the cell cycle in G2/M phase, and inhibits invasion and migration, potentially through inhibiting VEGFA/Akt/mTOR and Wnt/β-catenin/Myc pathways [4,7]. In ICC, Aurkb promotes cell proliferation, induces epithelial-mesenchymal transition (EMT), migration, and invasion, and in vivo promotes tumor growth and metastasis, regulating EMT-related genes via the PI3K/AKT signaling axis [5].
In conclusion, Aurkb is essential for mitosis and DDR. Its overexpression in various cancers promotes cancer progression, including cell proliferation, migration, invasion, and metastasis. Functional studies, especially those using loss-of-function approaches, have revealed its role in cancer-related biological processes, highlighting Aurkb as a potential therapeutic target in multiple cancer types [1,2,4,5,6,7].
References:
1. Zhu, Guoqing, Luo, Laihui, He, Yongzhu, Hu, Zhigao, Shan, Renfeng. 2024. AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway. In Molecular carcinogenesis, 63, 1814-1826. doi:10.1002/mc.23775. https://pubmed.ncbi.nlm.nih.gov/38874176/
2. Li, Linzhi, Jiang, Pengcheng, Hu, Weimin, Ning, Jinzhuo, Cheng, Fan. 2024. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2. In Journal of translational medicine, 22, 295. doi:10.1186/s12967-024-05099-6. https://pubmed.ncbi.nlm.nih.gov/38515112/
3. Marima, Rahaba, Hull, Rodney, Penny, Clement, Dlamini, Zodwa. 2021. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. In Mutation research. Reviews in mutation research, 787, 108376. doi:10.1016/j.mrrev.2021.108376. https://pubmed.ncbi.nlm.nih.gov/34083040/
4. Nie, Min, Wang, Yadong, Yu, Zenong, Liu, Ming, Zhao, Quan. 2020. AURKB promotes gastric cancer progression via activation of CCND1 expression. In Aging, 12, 1304-1321. doi:10.18632/aging.102684. https://pubmed.ncbi.nlm.nih.gov/31982864/
5. Ma, Peng, Hao, Ying, Wang, Wei, Yu, Kai-Huan, Wang, Wei-Xing. 2023. AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression. In Discover oncology, 14, 102. doi:10.1007/s12672-023-00707-1. https://pubmed.ncbi.nlm.nih.gov/37318676/
6. Wan, Bangbei, Huang, Yuan, Liu, Bo, Lu, Likui, Lv, Cai. 2019. AURKB: a promising biomarker in clear cell renal cell carcinoma. In PeerJ, 7, e7718. doi:10.7717/peerj.7718. https://pubmed.ncbi.nlm.nih.gov/31576249/
7. Wang, Zhen, Yu, Zhu, Wang, Gong-He, Chen, Jun-Qiang, Tian, Lei. 2020. AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT. In Cancer management and research, 12, 6947-6958. doi:10.2147/CMAR.S254250. https://pubmed.ncbi.nlm.nih.gov/32801915/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen